Initial clinical manifestations in a young male with -variant-associated diabetes.

Kazuhisa Akiba, Hiroaki Zukeran, Yukihiro Hasegawa, Maki Fukami
Author Information
  1. Kazuhisa Akiba: Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
  2. Hiroaki Zukeran: Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  3. Yukihiro Hasegawa: Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  4. Maki Fukami: Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.

Abstract

To date, heterozygous loss-of-function variants of have been identified in 13 families with diabetes. Here, we present initial clinical information regarding a young male with diabetes who carried a heterozygous nonsense variant of (p.Arg377Ter) previously reported in his family with diabetes. At 11 yr and 7 mo of age, the patient experienced severe thirst and hyperglycemia (331-398 mg/dL). Laboratory tests revealed elevated levels of glycated hemoglobin (HbA1c) (47 mmol/mL, 6.5%) and the Homeostatic Model for Insulin Resistance (HOMA-IR) (3.4). Blood glucose self-monitoring demonstrated grossly normal blood glucose levels, together with occasional postprandial hyperglycemia, and a few episodes of hypoglycemia. An oral glucose tolerance test revealed mild hyperglycemia and a delayed peak insulin level. His laboratory indices improved over two years with self-control of diet and exercise. These results indicate that the initial presentation of -variant-associated diabetes includes occasional hyperglycemia and hypoglycemia in response to changes in lifestyle. The possible association between variants and mild insulin resistance requires further validation in future studies.

Keywords

References

  1. Endocrinol Metab Clin North Am. 1989 Mar;18(1):185-201 [PMID: 2645126]
  2. Nat Commun. 2017 Oct 12;8(1):888 [PMID: 29026101]
  3. Diabet Med. 2020 Oct;37(10):1772-1776 [PMID: 31001871]
  4. J Diabetes Investig. 2021 Oct;12(10):1914-1918 [PMID: 33721395]
  5. Endocrine. 2021 Sep;73(3):752-757 [PMID: 34019234]
  6. N Engl J Med. 2001 May 3;344(18):1343-50 [PMID: 11333990]
  7. Cell Rep. 2014 Dec 24;9(6):2206-18 [PMID: 25497100]
  8. Gastroenterology. 2007 Dec;133(6):1796-805 [PMID: 18054552]
  9. Diabetes. 1999 Oct;48(10):2039-44 [PMID: 10512371]
  10. Pediatr Diabetes. 2021 Nov;22(7):960-968 [PMID: 34387403]
  11. Nature. 2023 Dec;624(7992):621-629 [PMID: 38049589]
  12. Diabetes Res Clin Pract. 2019 Jan;147:87-92 [PMID: 30481577]

Word Cloud

Created with Highcharts 10.0.0diabeteshyperglycemiainsulinglucoseheterozygousvariantsinitialclinicalyoungmalerevealedlevelsoccasionalhypoglycemiamild-variant-associatedresistancedateloss-of-functionidentified13familiespresentinformationregardingcarriednonsensevariantpArg377Terpreviouslyreportedfamily11yr7moagepatientexperiencedseverethirst331-398mg/dLLaboratorytestselevatedglycatedhemoglobinHbA1c47mmol/mL65%HomeostaticModelInsulinResistanceHOMA-IR34Bloodself-monitoringdemonstratedgrosslynormalbloodtogetherpostprandialepisodesoraltolerancetestdelayedpeaklevellaboratoryindicesimprovedtwoyearsself-controldietexerciseresultsindicatepresentationincludesresponsechangeslifestylepossibleassociationrequiresvalidationfuturestudiesInitialmanifestationsRFX6secretion

Similar Articles

Cited By

No available data.